click below
click below
Normal Size Small Size show me how
Drug Action Exam 3
Drug Action- Toxic substances
| Question | Answer |
|---|---|
| Toxidrome | Classic constellation of symptoms related to a toxin |
| Anticholinergic Toxidrome | Red as a beet, Hot as a hare, Mad as a hatter, Blind as a Bat, Dry as a bone, seizing like a squirrel |
| Naloxone | Used in Heroin abusers,over sedation, unknown coma patients |
| Flumazenil MOA | Mild to excessive benzodiazine sedation |
| Flumazenil dosing | 0.1mg/min up to 1mg |
| Physostigmine MOA | Carbamate that inhibits acetylcholinesterase |
| Physostigmine Use | Excessive muscaranic effects, Av block, bradycardia, seizures |
| Atropine MOA | Competitive antagonist of ACh at muscaranic receptor and in CNS |
| Atropine Use: | Clear secretions of the trachialbranchiol, Increase breathing (Sarin Gas) |
| Pralidoxime MOA | Nucleophillic oxime regenerates AChE at muscaranic, nicotinic and CNS sites by removing a phosphate group. Great to decrease muscle weakness. |
| Flumazenil DO not Use | Unknown coma, risk of seizure, risk of withdraw, abnormal ECG or vial signs, shorter T1/2 than BZD |
| CroFab USE | Binds the venom, therefore same dose for all 4-6IV vials |
| Ethanol MOA | inhibitor of active metabolite of Methanol or ethylene glycol |
| Fomepizole MOA | Specifice inhibitor of ALDH |
| Cyanide Antidote Kit | Amyl NItrile inhalent +Sodium Nitrile IV + Sodium thiosulfate |
| Amyl Nitrate & Sodium Nitrite Create | Methemoglobin that binds CN strongly Pulls it away from the ETC |
| Methylene Blue USE | Used to treat Metehomogloninemia coverts to hemoglobin |
| Octreotide MOA | Inhibits pancreatic insulin secretion |
| Octreotide Use If | Sulfonylurea ingestion suspected and at least 1 episode of hypoglycemia |
| Nomogram IF | rWithin 4-24 hours +Single ingestion |
| Treat with NAC IF | ALT >50IU/L and/or APAP >10mcg/mL |
| NAC PO Dose | 140 mg/kg bolus then 70mg/kg q 4 x 17 doses (72hrs) |
| NAC IV Dose | 150mg/kg over 15-60 minutes , then 50mg (12.5mg/kg/hr) over 4 hours, then 100mg (6.25mg/kg/hr) over 16 hours |
| NAC Children IV | 3.75 over 15-60minutes, 1.25ml/kg over 4 hours, 2.5ml/kg over 16 hours |
| NAC Effect | 100% effective if given w/in 8 hours of OD |
| NAC hepatic failure | 50% in Mortality, use of pressors, hepatic encephalopathy |
| NAC Alcoholic | Max dose safe |
| NAC-Transplant | Kings college criteria-1 pH <7.3 PT >100 sec (INR>6) and SCR >3.4 AND III or IV encephalophy |
| Liver failure | High lactate |
| ASA Adult toxic dose | 150mg/kg |
| ASA min lethal dose | 450mg/kg |
| ASA MOA | Uncoupleted oxidative phosphorylation + Stimulation of respiratory center+ Inhibit COX+ alter capillary permeability |
| Clinical Effects of ASA OD | Acid/Base (anion gap)+ cerebral /pulmonary edema+ CNS (agigation, seizures) Tinnitis, GI |
| ASA Elimination | Toxic ASA levels >30ml/DL + give 1-2 amps NaHco3 blous and then 3 amps +1 L D5W +20meQ Potassium keep Ph >7.5 |
| HD ASA | >90-100mg/DL |
| Elderly ASA toxicity | >50mg/mL |
| Gi decontimination | Lavage (suction) +Charchol+ Whole bowel irrigation |
| CCB +BB | Decrease:SA HR, Conduction, contractility=hypotension and increased ERP |
| Propranolol | CNS penetration, CNS depression & seizure, bradycardia, dysrhythmia, hypoglycemia |
| CCB MOA | Block calcium channel, vasodialation, chronotropy (SA node), hyperglycemia, Peak in 0.5-6 hours |
| CCB+ BB OD treatment | 500 ML fluides, Atropine (bradycardia s/s) Dopamine, Calcium(1-2 amps), glucagon(2-5 amps) |
| Digoxin acute OD | Digibind 10-20vials |
| Digocin chronic OD | Digibind 2-5 vials |
| Digoxin | Watch hypokalemia and MG |
| Digocin MOA | vagal stimulation and sinus bradycardia/arrest, PR prongulation, nodal block |
| Digoxin:Acute toxicity | N/V, Super ventricular tachycardia, with heart blcok or bradydydsrhythmias, hyperkalemia, DIg level markedly elevated |